Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2008-04-144758PMID 18676880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation induces hemorrhage in thrombocytopenia

  2010cited by this paper
• Antiplatelet therapy for acute ischaemic stroke.

  2008cited by this paper
• Reduced incidence of ischemic stroke in patients with severe factor XI deficiency.

  2008cited by this paper
• Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)

  2008cited by this paper
• Polymorphisms in Platelet Glycoprotein 1bα and Factor VII and Risk of Ischemic Stroke: A Meta-Analysis

  2008cited by this paper
• Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA: A Meta-Analysis

  2008cited by this paper
• Rodent models of ischemic stroke: a useful tool for stroke drug development.

  2008cited by this paper
• Inflammation induces hemorrhage in thrombocytopenia.

  2008cited by this paper
• Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data

  2008cited by this paper
• Blocking of Platelets or Intrinsic Coagulation Pathway–Driven Thrombosis Does Not Prevent Cerebral Infarctions Induced by Photothrombosis

  2008cited by this paper
• Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors.

  2008cited by this paper
• Kindlin-3 is essential for integrin activation and platelet aggregation

  2008cited by this paper
• Anticoagulants for acute ischaemic stroke.

  2008cited by this paper
• The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction

  2008cited by this paper
• Targeting Platelets in Acute Experimental Stroke: Impact of Glycoprotein Ib, VI, and IIb/IIIa Blockade on Infarct Size, Functional Outcome, and Intracranial Bleeding

  2007cited by this paper
• Glycoprotein IIb-IIIa Inhibitors for Acute Ischemic Stroke

  2007cited by this paper
• In vivo thrombus formation

  2007cited by this paper
• Platelet adhesion receptors do not modulate infarct volume after a photochemically induced stroke in mice.

  2007cited by this paper
• Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

  2007cited by this paper
• Activation of Platelet Function Through G Protein–Coupled Receptors Platelets As Immune Cells: Bridging Inflammation and Cardiovascular Disease In Vivo Thrombus Formation in Murine Models Clinical Aspects of Platelet Inhibitors and Thrombus Formation Platelet Adhesion

  2007cited by this paper
• Talin is required for integrin-mediated platelet function in hemostasis and thrombosis

  2007cited by this paper
• Mouse Model of In Situ Thromboembolic Stroke and Reperfusion

  2007cited by this paper
• Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo

  2007cited by this paper
• Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

  2007cited by this paper
• Guidelines for the Early Management of Adults With Ischemic Stroke

  2007cited by this paper
• Calcium signalling in lymphocyte activation and disease

  2007cited by this paper
• Reduced Poststroke Mortality in Patients With Stroke and Atrial Fibrillation Treated With Anticoagulants: Results From a Danish Quality-Control Registry of 22 179 Patients With Ischemic Stroke

  2007cited by this paper
• Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study

  2007cited by this paper
• The intrinsic pathway of coagulation: a target for treating thromboembolic disease?

  2007cited by this paper
• An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice.

  2007cited by this paper
• Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation

  2007cited by this paper
• High von Willebrand Factor Levels Increase the Risk of First Ischemic Stroke: Influence of ADAMTS13, Inflammation, and Genetic Variability

  2006cited by this paper
• Are hemostasis and thrombosis two sides of the same coin?

  2006cited by this paper
• The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis

  2006cited by this paper
• Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures.

  2006cited by this paper
• 1,026 Experimental treatments in acute stroke

  2006cited by this paper
• Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization

  2006cited by this paper
• Rational humanization of the powerful antithrombotic anti-GPIbα antibody: 6B4

  2006cited by this paper
• Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy

  2006cited by this paper
• Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

  2006cited by this paper
• Preclinical evaluation of the neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused stroke.

  2006cited by this paper
• Endovascular recanalization therapy in acute ischemic stroke.

  2006cited by this paper
• Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4.

  2006cited by this paper
• Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

  2006cited by this paper
• Platelet Adhesion Via Glycoprotein IIb Integrin Is Critical for Atheroprogression and Focal Cerebral Ischemia: An In Vivo Study in Mice Lacking Glycoprotein IIb

  2005cited by this paper
• Aggressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar Occlusion: Combined Local Fibrinolysis and Intravenous Abciximab in Acute Vertebrobasilar Stroke Treatment (FAST) Results of a Multicenter Study

  2005cited by this paper
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

  2005cited by this paper
• Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas

  2005cited by this paper
• The Rapid Anticoagulation Prevents Ischemic Damage Study in Acute Stroke – Final Results from the Writing Committee

  2005cited by this paper
• Defective thrombus formation in mice lacking coagulation factor XII

  2005cited by this paper
• Intravenous Heparin Started Within the First 3 Hours After Onset of Symptoms as a Treatment for Acute Nonlacunar Hemispheric Cerebral Infarctions

  2005cited by this paper
• Heparin use in acute ischaemic stroke: does evidence change practice?

  2005cited by this paper
• CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke

  2005cited by this paper
• Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association.

  2005cited by this paper
• Multimodal Therapy for the Treatment of Severe Ischemic Stroke Combining GPIIb/IIIa Antagonists and Angioplasty After Failure of Thrombolysis

  2005cited by this paper
• The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions

  2004cited by this paper
• Erratum: CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation

  2004cited by this paper
• Anticoagulants for acute ischaemic stroke.

  2004cited by this paper
• Role of tissue factor in hemostasis, thrombosis, and vascular development.

  2004cited by this paper
• Platelet physiology and thrombosis.

  2004cited by this paper
• Platelet–Leukocyte–Endothelial Cell Interactions after Middle Cerebral Artery Occlusion and Reperfusion

  2004cited by this paper
• CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation

  2004cited by this paper
• Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.

  2003cited by this paper
• Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association

  2003cited by this paper
• Antiplatelet therapy for acute ischaemic stroke.

  2003cited by this paper
• Immediate reocclusion following a successful thrombolysis in acute stroke: A pilot study

  2003cited by this paper
• Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo.

  2003cited by this paper
• Signaling events underlying thrombus formation

  2003cited by this paper
• Platelet-collagen interaction: is GPVI the central receptor?

  2003cited by this paper
• Cerebral Microvessel Responses to Focal Ischemia

  2003cited by this paper
• Emergent Use of Anticoagulation for Treatment of Patients With Ischemic Stroke

  2002cited by this paper
• Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons.

  2002cited by this paper
• Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody.

  2002cited by this paper
• Flow cytometric detection of activated mouse integrin αIIbβ3 with a novel monoclonal antibody

  2002cited by this paper
• Use of Intravenous Heparin by North American Neurologists: Do the Data Matter?

  2002cited by this paper
• Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion.

  2001cited by this paper
• Long-Term Antithrombotic Protection by in Vivo Depletion of Platelet Glycoprotein VI in Mice

  2001cited by this paper
• The Vascular Biology of the Glycoprotein Ib-IX-V Complex

  2001cited by this paper
• Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.

  2001cited by this paper
• Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia.

  2000cited by this paper
• Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

  2000cited by this paper
• Management patterns and costs of acute ischemic stroke : an international study. For the Stroke Economic Analysis Group.

  2000cited by this paper
• Integrin αIIbβ3 Inhibitor Preserves Microvascular Patency in Experimental Acute Focal Cerebral Ischemia

  2000cited by this paper
• Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome.

  2000cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Targeted Inhibition of Intrinsic Coagulation Limits Cerebral Injury in Stroke without Increasing Intracerebral Hemorrhage

  1999cited by this paper
• The Glycoprotein Ib-IX-V Complex Is a Platelet Counterreceptor for P-Selectin

  1999cited by this paper
• Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury.

  1999cited by this paper
• The Platelet Collagen Receptor Glycoprotein VI Is a Member of the Immunoglobulin Superfamily Closely Related to FcαR and the Natural Killer Receptors*

  1999cited by this paper
• Quinine-dependent antibodies bind a restricted set of epitopes on the glycoprotein Ib-IX complex: characterization of the epitopes.

  1998cited by this paper
• Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.

  1998cited by this paper
• The role of platelets in ischemic stroke

  1998cited by this paper
• Genetic Defects in the Control of Growth Hormone Secretion

  1998cited by this paper
• Quinine-Dependent Antibodies Bind a Restricted Set of Epitopes on the Glycoprotein Ib-IX Complex: Characterization of the Epitopes

  1998cited by this paper
• Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.

  1998cited by this paper
• Bernard-Soulier syndrome.

  1998cited by this paper
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.

  1997cited by this paper
• Integrin signaling in vascular biology.

  1997cited by this paper
• Perspectives series: cell adhesion in vascular biology. Integrin signaling in vascular biology.

  1997cited by this paper
• CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group.

  1997cited by this paper

• Development of Zafirlukast Analogues for Improved Antithrombotic Activity Through Thiol Isomerase Inhibition

  2025cites this paper
• Targeting the Contact-Kinin System: A Cyclopeptide with Anti-Thromboinflammatory Properties Against Stroke.

  2025cites this paper
• Signaling Pathways and Promising Small‐Molecule Therapeutic Agents for Ischemic Stroke

  2025cites this paper
• The critical role of Sirt1 in ischemic stroke

  2025cites this paper
• The soluble guanylate cyclase (sGC) stimulator vericiguat inhibits platelet activation and thrombosis.

  2025cites this paper
• Recent advances of engineering cell membranes for nanomedicine delivery across the blood–brain barrier

  2025cites this paper
• Perfluoroalkyl and polyfluoroalkyl substances interact with platelet glycoprotein Ibα and exacerbate thrombosis.

  2025cites this paper
• The impact of glycolysis on ischemic stroke: from molecular mechanisms to clinical applications

  2025cites this paper
• Factor XI and Atrial Fibrillation: A Mismatched Pairing?

  2025influential citation
• The Discovery of a Novel Anticoagulant Mechanism: Factor XI Activation Inhibitors.

  2025cites this paper
• From first responders to outcome modulators: The evolving paradigm of neutrophils in ischemic stroke and thrombolysis.

  2025cites this paper
• Cell membrane-camouflaged nanomedicines for enhanced thrombolysis and blood-brain barrier penetration in ischemic stroke therapy

  2025cites this paper
• A minimally invasive thrombotic model to study stroke in awake mice

  2025cites this paper
• Traditional Chinese medicine in cerebral infarction: Integrative strategies and future directions.

  2025cites this paper
• Poly (ADP-ribose) Polymerase-1 modulations in the genesis of thrombosis

  2024cites this paper
• Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy

  2024cites this paper
• Ginsenoside Rb1 in cardiovascular and cerebrovascular diseases: A review of therapeutic potentials and molecular mechanisms

  2024cites this paper
• A minimally invasive thrombotic stroke model to study circadian rhythm in awake mice

  2024cites this paper
• Diet and Nutraceuticals for treatment and prevention of primary and secondary stroke: emphasis on nutritional antiplatelet and antithrombotic agents.

  2024cites this paper
• DISRUPTION OF HEMOSTASIS IN THE PATHOGENESIS OF ISCHEMIC STROKE

  2024cites this paper
• Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy

  2024cites this paper
• Guhong injection attenuates brain injury and promotes neuroprotection after acute ischemic stroke.

  2024cites this paper
• Brain-targeted ginkgolide B-modified carbonized polymer dots for alleviating cerebral ischemia reperfusion injury.

  2023cites this paper
• MAGT1 Deficiency Dysregulates Platelet Cation Homeostasis and Accelerates Arterial Thrombosis and Ischemic Stroke in Mice

  2023cites this paper
• Mesenchymal Stem Cell Therapy for Ischemic Stroke in Animal Model: A Systematic Review

  2023cites this paper
• The Protective Effects of Lavender officinalis Extract Against Impairment of Antioxidant–Detoxification System Induced by Glucose Deprivation Through Nrf2 Expression

  2023cites this paper
• Neuroprotective Effects of Geopung-Chunghyuldan Based on Its Salvianolic Acid B Content Using an In Vivo Stroke Model

  2023cites this paper
• Role of traditional Chinese medicine monomers in cerebral ischemia/reperfusion injury:a review of the mechanism

  2023cites this paper
• Human milk oligosaccharide, 2′-Fucosyllactose, attenuates platelet activation in arterial thrombosis

  2022cites this paper
• Protective effects of rivaroxaban against cisplatin-induced testicular damage in rats: Impact on oxidative stress, coagulation, and p-NF-κB/VCAM-1 signaling.

  2022cites this paper
• Screening and identification of biomarkers associated with the immune infiltration of intracerebral hemorrhage

  2022cites this paper
• Novel contact–kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke

  2022cites this paper
• Bioresponsive nanoplatforms for imaging and therapy of cardiovascular diseases

  2022cites this paper
• Platelets, Thromboinflammation and Neurovascular Disease

  2022cites this paper
• Cellular and Molecular Targets for Non-Invasive, Non-Pharmacological Therapeutic/Rehabilitative Interventions in Acute Ischemic Stroke

  2022cites this paper
• Endothelial caveolin-1 regulates cerebral thrombo-inflammation in acute ischemia/reperfusion injury

  2022cites this paper
• Awareness Level of Nurses Regarding Management of Stroke Patients in Rajshahi Medical College Hospital

  2021cites this paper
• Double‐Network Hydrogel Armored Decellularized Porcine Pericardium as Durable Bioprosthetic Heart Valves

  2021cites this paper
• Ref-1 protects against FeCl3-induced thrombosis and tissue factor expression via the GSK3β–NF-κB pathway

  2021cites this paper
• Elastase inhibitor agaphelin protects from acute ischemic stroke in mice by reducing thrombosis, blood-brain barrier damage, and inflammation.

  2021cites this paper
• Design, synthesis, and neuroprotective effects of novel hybrid compounds containing edaravone analogue and 3-n-butylphthalide ring-opened derivatives.

  2021cites this paper
• Cell membrane-coated nanoparticles and their biomedical applications

  2021cites this paper
• Per-pass analysis of recanalization and good neurological outcome in thrombectomy for stroke: Systematic review and meta-analysis

  2021cites this paper
• Associations of coagulation factor X and XI with incident acute coronary syndrome and stroke: A nested case‐control study

  2021cites this paper
• Dynamic nanoassemblies for imaging and therapy of neurological disorders.

  2021cites this paper
• Factor XII(a) inhibitors: a review of the patent literature

  2021cites this paper
• Effectiveness of Bilateral Task-Oriented Exercises and Mirror Therapy to Improve Hand Function in Hemiparetic Stroke

  2021cites this paper
• EFFECT OF COMBINING TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION WITH EXERCISE REGIME ON SPASTICITY AND UPPER EXTREMITY FUNCTION FOLLOWING CHRONIC MIDDLE CEREBRAL ARTERY STROKE

  2020cites this paper
• Ultrasound controlled anti-inflammatory polarization of platelet decorated microglia for targeted ischemic stroke therapy.

  2020cites this paper
• Overview of Salvia miltiorrhiza as a Potential Therapeutic Agent for Various Diseases: An Update on Efficacy and Mechanisms of Action

  2020cites this paper
• Pathophysiologie des Schlaganfalls

  2020cites this paper
• Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost

  2020cites this paper
• Synthetic Ruthenium Complex TQ-6 Potently Recovers Cerebral Ischemic Stroke: Attenuation of Microglia and Platelet Activation

  2020cites this paper
• Effects of Acanthopanax senticosus (Rupr. & Maxim.) Harms on cerebral ischemia-reperfusion injury revealed by metabolomics and transcriptomics.

  2020cites this paper
• The Correlation Between Ischemic Stroke and Thrombosis by Nanoscale Biomarker Analysis

  2020cites this paper
• Study on Electrolyte Abnormality and Quality Outcomes in the Management of Stroke

  2020cites this paper
• Standardization and Validation of Fluorescence-Based Quantitative Assay to Study Human Platelet Adhesion to Extracellular-Matrix in a 384-Well Plate

  2020cites this paper
• Proteomics Reveals Plasma Biomarkers for Ischemic Stroke Related to the Coagulation Cascade

  2020cites this paper
• Regulation of GABAB Receptors under Excitotoxic Conditions: Contribution to Neuronal Death and Potential Implications to Novel Therapeutic Approaches

  2019cites this paper
• Current and future perspective on the treatment of ischemic stroke

  2019cites this paper
• Recent Advances in Tissue plasminogen activator-based nanothrombolysis for ischemic stroke

  2019cites this paper
• Corrigendum: Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats

  2019cites this paper
• Achyranthes bidentata polypeptide k improves long-term neurological outcomes through reducing downstream microvascular thrombosis in experimental ischemic stroke.

  2019cites this paper
• [A Case of Successful Thrombolysis on the Verge of a Reperfusion Revolution in Coronary Cardiology and Vascular Neurology].

  2019cites this paper
• Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases

  2019cites this paper
• Sequentially Site-Specific Delivery of Thrombolytics and Neuroprotectant for Enhanced Treatment of Ischemic Stroke.

  2019cites this paper
• New insight in understanding and exploring optimal biomarkers in stroke: Key diagnostic markers for clinical treatment

  2019cites this paper
• Micro RNA 146a gene variant / TNF-α/ IL-6/ IL-1 β; A cross-link axis inbetween oxidative stress, endothelial dysfunction and neuro-inflammation in acute ischemic stroke and chronic schizophrenic patients.

  2019cites this paper
• Loss of Orai2-Mediated Capacitative Ca2+ Entry Is Neuroprotective in Acute Ischemic Stroke.

  2019cites this paper
• Crystal structure and receptor-interacting residues of MYDGF — a protein mediating ischemic tissue repair

  2019cites this paper
• Biomechanical thrombosis: the dark side of force and dawn of mechano-medicine

  2019cites this paper
• Physical Impairments Associated with Diseases: A Pathophysiological Approach

  2019cites this paper
• Extended D-E knob-hole interaction sites in fibrin polymerisation, clot formation and clot mechanics

  2019cites this paper
• Cell Type-Specific Mechanisms in the Pathogenesis of Ischemic Stroke: The Role of Apoptosis Signal-Regulating Kinase 1

  2018cites this paper
• A novel rationale for targeting FXI: Insights from the hemostastic miRNA targetome for emerging anticoagulant strategies

  2018cites this paper
• Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion

  2018cites this paper
• Fibrinolysis: strategies to enhance the treatment of acute ischemic stroke

  2018cites this paper
• Platelet Function Analyzer-200 P2Y Results Are Predictive of the Risk of Major Adverse Cardiac Events in Korean Patients Receiving Clopidogrel Therapy Following Acute Coronary Syndrome

  2018cites this paper
• Predicting recovery of ability to walk ten meters or more independently at eight weeks and six months after stroke

  2018cites this paper
• Analysis of association study between polymorphic variants of genes encoding matrix metalloproteinases types 1 and 2 and the risk of ischemic stroke: pilot study in the central Russia population

  2018cites this paper
• Mouse Platelet Ral GTPases Control P-Selectin Surface Expression, Regulating Platelet–Leukocyte Interaction

  2018cites this paper
• Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats

  2018cites this paper
• Platelets Drive Inflammation and Target Gray Matter and the Retina in Autoimmune-Mediated Encephalomyelitis

  2018cites this paper
• A facile approach for synthesis of nano-CeO2 particles loaded co-polymer matrix and their colossal role for blood-brain barrier permeability in Cerebral Ischemia.

  2018cites this paper
• Snake venom components in medicine: From the symbolic rod of Asclepius to tangible medical research and application.

  2018cites this paper
• Reperfusion injury in the age of revascularization

  2018cites this paper
• Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow

  2018cites this paper
• Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis

  2018cites this paper
• The role of neutrophils in thrombosis.

  2018cites this paper
• EVALUATION OF INVITRO THROMBOLYTIC, ANTI-INFLAMMATORY AND ISCHEMIC PROTECTIVE EFFECT OF ETHANOL AND CHLOROFORM FRACTIONS OF TAXILLUS HEYNEANUS CRUDE EXTRACT

  2017cites this paper
• Molecular Mechanisms of Inflammation in Stroke

  2017cites this paper
• Therapeutic role of nitric oxide as emerging molecule.

  2017cites this paper
• Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.

  2017cites this paper
• Nurden : Platelets , inflammation and tissue regeneration

  2017cites this paper
• Multi-Targeting Andrographolide, a Novel NF-κB Inhibitor, as a Potential Therapeutic Agent for Stroke

  2017cites this paper
• Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke

  2017cites this paper
• Enhanced Procoagulant Activity on Blood Cells after Acute Ischemic Stroke

  2017cites this paper
• Bone morphogenetic protein 9 serves a protective role in response to ischemic-reperfusion in the brain by promoting ERK activation

  2017cites this paper
• Platelet secretion is crucial to prevent bleeding in the ischemic brain but not in the inflamed skin or lung in mice.

  2017cites this paper
• ROCK as a therapeutic target for ischemic stroke

  2017cites this paper